Outcomes After Percutaneous Coronary Intervention in Patients With a History of Cerebrovascular Disease: Insights From the Blue Cross Blue Shield of Michigan Cardiovascular Consortium

被引:16
|
作者
Song, Chris [1 ]
Sukul, Devraj [2 ]
Seth, Milan [2 ]
Wohns, David [3 ]
Dixon, Simon R. [4 ]
Slocum, Nicklaus K. [5 ]
Gurm, Hitinder S. [2 ,6 ]
机构
[1] Univ Michigan, Dept Internal Med, Div Cardiovasc Med, Med Sch, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Dept Internal Med, Div Cardiovasc Med, Ann Arbor, MI 48109 USA
[3] Spectrum Hlth, Div Cardiol, Grand Rapids, MI USA
[4] Beaumont Hosp, Dept Cardiovasc Med, Royal Oak, MI USA
[5] Traverse Heart & Vasc, Dept Cardiol, Grand Traverse Heart Associates, Traverse City, MI USA
[6] VA Ann Arbor Healthcare Syst, Dept Internal Med, Div Cardiol, Ann Arbor, MI USA
基金
美国国家卫生研究院;
关键词
ischemic attack; transient; outcome assessment (health care); percutaneous coronary intervention; risk factors; stroke; PAYMENT VARIATION; STROKE; CALCIFICATION; PRASUGREL; ACCIDENTS; MORTALITY; DRIVERS;
D O I
10.1161/CIRCINTERVENTIONS.118.006400
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Because of shared risk factors between coronary artery disease and cerebrovascular disease, patients with a history of transient ischemic attack (TIA) or stroke are at greater risk of developing coronary artery disease, which may require percutaneous coronary intervention (PCI). However, there remains a paucity of research examining outcomes after PCI in these patients. Methods and Results-We analyzed consecutive patients who underwent PCI between January 1, 2013, and March 31, 2016, at 47 Michigan hospitals and identified those with a history of TIA/stroke. We used propensity score matching to adjust for differences in baseline characteristics and compared in-hospital outcomes between patients with and without a history of TIA/stroke. We compared rates of 90-day readmission and long-term mortality in a subset of patients. Among 98730 patients who underwent PCI, 10915 had a history of TIA/stroke. After matching (n=10618 per group), a history of TIA/stroke was associated with an increased risk of in-hospital stroke (adjusted odds ratio, 2.04; 95% confidence interval, 1.41-2.96; P<0.001). There were no differences in the risks of other in-hospital outcomes. In a subset of patients with postdischarge data, a history of TIA/stroke was associated with increased risks of 90-day readmission (adjusted odds ratio, 1.22; 95% confidence interval, 1.09-1.38; P<0.001) and long-term mortality (hazard ratio, 1.23; 95% confidence interval, 1.07-1.43; P=0.005). Conclusions-A history of TIA/stroke was common in patients who underwent PCI and was associated with increased risks of in-hospital stroke, 90-day readmission, and long-term mortality. Given the devastating consequences of post-PCI stroke, patients with a history of TIA/stroke should be counseled on this increased risk before undergoing PCI.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] The association between patient race, treatment, and outcomes of patients undergoing contemporary percutaneous coronary intervention: Insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2)
    Khambatta, Sherezade
    Seth, Milan
    Rosman, Howard S.
    Share, David
    Aronow, Herbert D.
    Moscucci, Mauro
    LaLonde, Thomas
    Dixon, Simon R.
    Gurm, Hitinder S.
    AMERICAN HEART JOURNAL, 2013, 165 (06) : 893 - +
  • [22] Clinical outcomes of elective contemporary percutaneous coronary interventions in octogenarians: Insight from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium
    Khanal, SE
    Smith, DE
    Share, D
    Gardin, J
    Lauer, M
    Kline-Rogers, E
    Moscucci, M
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (05) : 17A - 17A
  • [23] The Comparative Safety and Effectiveness of Bivalirudin versus Heparin Monotherapy in Patients on Dialysis Undergoing Percutaneous Coronary Intervention: Insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium
    Sukul, Devraj
    Seth, Milan
    Schreiber, Theodore
    Khandelwal, Akshay
    Cannon, Louis A.
    LaLonde, Thomas A.
    Gurm, Hitinder S.
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2017, 90 (05) : 724 - 732
  • [24] READMISSION AND LONG-TERM MORTALITY IN OLDER PATIENTS TREATED WITH TICAGRELOR VERSUS PRASUGREL AFTER PERCUTANEOUS CORONARY INTERVENTION: INSIGHTS FROM THE BLUE CROSS BLUE SHIELD OF MICHIGAN CARDIOVASCULAR CONSORTIUM
    Sukul, Devraj
    Seth, Milan
    Dupree, James M.
    Khandelwal, Akshay
    Dixon, Simon
    Wohns, David
    LaLonde, Thomas
    Gurm, Hitinder
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (11) : 1020 - 1020
  • [25] Association of Anemia With Outcomes in Patients Undergoing Percutaneous Peripheral Vascular Intervention: Insights From the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2 VIC)
    Ambulgekar, Nikhil V.
    Grey, Scott F.
    Rosman, Howard S.
    Othman, Hussein
    Davis, Thomas P.
    Nypaver, Timothy J.
    Schreiber, Theodore
    Yamasaki, Hiroshi
    Lalonde, Thomas A.
    Henke, Peter K.
    Gurm, Hitinder S.
    Mehta, Rajendra H.
    Grossman, P. Michael
    JOURNAL OF INVASIVE CARDIOLOGY, 2018, 30 (01): : 35 - 42
  • [26] Dramatic Impact of a Liaison-Mediated Referral Strategy on Cardiac Rehabilitation Participation After Percutaneous Coronary Intervention: Insights From the Blue Cross Blue Shield of Michigan Cardiovascular Consortium
    Mansour, Alexandra I.
    Seth, Milan
    Thompson, Mike P.
    Casey, Mary
    Keteyian, Steven J.
    Smith, Frank
    Gurm, Hitinder S.
    Sukul, Devraj
    CIRCULATION, 2023, 148
  • [27] The Zip Code Jeopardy: Living in Disadvantaged Areas is Associated With Significantly Increased Mortality After Percutaneous Coronary Intervention: Insights From the Blue Cross Blue Shield of Michigan Cardiovascular Consortium
    Sukul, Devraj
    Seth, Milan
    Spehar, Stephanie
    Thompson, Michael
    Bonifacio, Daniel
    Lee, Daniel
    Rizk, Maged
    Osman, Abdul
    Gurm, Hitinder S.
    CIRCULATION, 2020, 142
  • [28] Underutilization of Radial Access in Patients Undergoing Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction Insights From the Blue Cross Blue Shield of Michigan Cardiovascular Consortium
    Howe, Michael J.
    Seth, Milan
    Riba, Arthur
    Hanzel, George
    Zainea, Mark
    Gurm, Hitinder S.
    CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2015, 8 (05)
  • [29] COST VERSUS CONTRAINDICATION: THE COMPARATIVE SAFETY OF ABCIXIMAB VERSUS EPTIFIBATIDE IN PATIENTS ON DIALYSIS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: INSIGHTS FROM THE BLUE CROSS BLUE SHIELD OF MICHIGAN CARDIOVASCULAR CONSORTIUM
    Sukul, Devraj
    Seth, Milan
    Schreiber, Theodore
    Hanzel, George
    Khandelwal, Akshay
    Cannon, Louis
    LaLonde, Thomas
    Miller, Ronald
    Gurm, Hitinder
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (13) : 288 - 288
  • [30] The comparative safety of abciximab versus eptifibatide in patients on dialysis undergoing percutaneous coronary intervention: Insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2)
    Sukul, Devraj
    Seth, Milan
    Schreiber, Theodore
    Hanzel, George
    Khandelwal, Akshay
    Cannon, Louis A.
    Lalonde, Thomas A.
    Gurm, Hitinder S.
    JOURNAL OF INTERVENTIONAL CARDIOLOGY, 2017, 30 (04) : 291 - 300